Russell Investments Group
CNST

Russell Investments Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Russell Investments Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,582
Closed -$621K – 3364
2021
Q1 		$621K Sell
26,582
-15,865
-37% -$481K ﹤0.01% 2434
2020
Q4 		$1.22M Hold
42,447
– – ﹤0.01% 2029
2020
Q3 		$859K Buy
+42,447
New +$1.04M ﹤0.01% 2144

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group's CNST Position: Q2 2021 in Review

Russell Investments Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 26,582 shares — an estimated $621K sold.

Russell Investments Group first reported a position in CNST in Q3 2020 and held it in 3 quarters. The position peaked at $1.22M in Q4 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Russell Investments Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 26,582 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $621K.
  • Russell Investments Group first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2020 and held it in 3 quarters.
  • Russell Investments Group's Constellation Pharmaceuticals, Inc. position peaked at $1.22M in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.